Skip to main content
. 2020 Dec 14;2020:6661642. doi: 10.1155/2020/6661642

Figure 3.

Figure 3

Repeated WY-14643 administration reduced inflammation in CCI rats by activating PPARα. (a) WY-14643 reduced IL-1β, IL-6, and TNF-α levels in serum of CCI rats, whereas GW6471 and si-SIRT1 reversed the anti-inflammatory effect. (b) WY-14643 reduced IL-1β, IL-6, and TNF-α levels in the spinal cord of CCI rats, whereas GW6471 and si-SIRT1 reversed the anti-inflammatory effect.